TABLE 2.
Region | Primers | MgCl2concn (mM) | Primer concn (μM) | Conditions for:
|
No. of cycles | Enzyme(s)a | |||||
---|---|---|---|---|---|---|---|---|---|---|---|
Denaturation
|
Annealing
|
Extension
|
|||||||||
°C | s | °C | s | °C | s | ||||||
Promoter 1 | NRPROM-F-NRI2E2-R | 1.50 | 0.2 | 94 | 30 | 55 | 30 | 72 | 60 | 35 | A |
NRPROM3-F-NRPROM2-R | 1.50 | 0.2 | 94 | 30 | 54 | 30 | 72 | 60 | 35 | A | |
Promoter 2 | NRPROMD-F-NRPROM3-R | 1.50 | 0.2 | 94 | 30 | 53 | 30 | 72 | 60 | 35 | A |
NRPROMD-F-NRPROM2-R | 1.50 | 0.2 | 94 | 30 | 53 | 30 | 72 | 60 | 35 | A | |
E2-E7 | NRE2-F-NRE7-R | 2.25 | 0.3 | 92 | 10 | 58 | 30 | 68 | 240 | 10 | B |
92 | 10 | 58 | 30 | 68 | 240b | 25 | |||||
E2-E9 | NRE2-F-NRE9-R | 1.50 | 0.2 | 94 | 30 | 53 | 30 | 72 | 60 | 35 | A |
E7-E15 | NRE7-F-NRE3′UTR-R | 1.50 | 0.2 | 94 | 30 | 55 | 30 | 72 | 60 | 35 | A |
E6-I6 | NRE6I6-F-NRI6-R | 2.00 | 0.3 | 94 | 30 | 63c | 30 | 72 | 30 | 20 | D |
94 | 30 | 53 | 30 | 72 | 30 | 10 | |||||
E7-E10 | NRE7-F-NRE10-R | 1.50 | 0.3 | 94 | 15 | 55 | 30 | 68 | 480 | 35 | C |
E9-E11 | NRE9-F-NRE11-R2 | 1.50 | 0.3 | 94 | 15 | 55 | 30 | 68 | 480 | 35 | C |
E10-E15 | NRE10-F-NR3′UTR-R | 1.50 | 0.3 | 94 | 15 | 55 | 30 | 68 | 480 | 35 | C |
Microsatellite | NRMICRI1-F-NRMICR1-R | 1.50 | 0.2 | 94 | 30 | 55 | 30 | 72 | 30 | 25 | A |
Intron 10 | NRE10-F-NRE11-R2 | 1.50 | 0.2 | 95 | 30 | 55 | 30 | 72 | 45 | 35 | E |
Enzymes and commercial kits: A, Taq polymerase (Invitrogen); B, Expand long-template PCR system (system 3; Taq and Pwo polymerases) (Roche); C, Platinum Pfx DNA polymerase (with enhancer solution ×1) (Invitrogen); D, AmpliTaq Gold (Applied Biosystems); and E, GC-Rich PCR amplification system (0.5 M GC rich resolution solution and Taq and Tgo polymerases).
Plus 20 s per cycle.
Minus 0.5°C per cycle.